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Reactive oxygen and nitrogen species
Oxidative modifications
Disulfide bridges
A B S T R A C T
Many current anti-cancer therapies rely on increasing the intracellular reactive oxygen and nitrogen species
(RONS) contents with the aim to induce irreparable damage, which subsequently results in tumor cell death. A
novel tool in cancer therapy is the use of cold atmospheric plasma (CAP), which has been found to be very
effective in the treatment of many different cancer cell types in vitro as well as in vivo, mainly through the vast
generation of RONS. One of the key determinants of the cell's fate will be the interaction of RONS, generated by
CAP, with important proteins, i.e. redox-regulatory proteins. One such protein is cytoglobin (CYGB), a recently
discovered globin proposed to be involved in the protection of the cell against oxidative stress. In this study, the
effect of plasma-produced RONS on CYGB was investigated through the treatment of CYGB with CAP for dif-
ferent treatment times. Spectroscopic analysis of CYGB showed that although chemical modifications occur, its
secondary structure remains intact. Mass spectrometry experiments identified these modifications as oxidations
of mainly sulfur-containing and aromatic amino acids. With longer treatment time, the treatment was also found
to induce nitration of the heme. Furthermore, the two surface-exposed cysteine residues of CYGB were oxidized
upon treatment, leading to the formation of intermolecular disulfide bridges, and potentially also intramolecular
disulfide bridges. In addition, molecular dynamics and docking simulations confirmed, and further show, that
the formation of an intramolecular disulfide bond, due to oxidative conditions, affects the CYGB 3D structure,
thereby opening the access to the heme group, through gate functioning of His117. Altogether, the results ob-
tained in this study (1) show that plasma-produced RONS can extensively oxidize proteins and (2) that the
oxidation status of two redox-active cysteines lead to different conformations of CYGB.
1. Introduction
The use of cold atmospheric plasma (CAP) has attracted a lot of
attention over the past few years and has already found many biome-
dical applications, including wound healing [1], sterilization [2], bio-
film removal [3], blood coagulation [4], and more recently cancer
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therapy [5]. CAP is a plasma (i.e., ionized gas) in which the high-
temperature electrons are in non-equilibrium with the low-temperature
heavy particles, thereby keeping the gas itself near room temperature
and making it suitable for treatment of living cells and tissues. Plasma is
a mixture of various components, including charged particles (ions,
electrons), reactive neutral species (reactive oxygen and nitrogen spe-
cies; RONS), UV radiation, and electromagnetic fields [6]. Of those,
RONS are hypothesized to mediate the effects observed in biological
systems as they are known to be involved in rapid reactions with im-
portant biomolecules such as proteins and lipids [7,8]. In the last few
years, CAP was shown to be able to induce apoptotic cell death in
numerous different cancer cell types [9–15]. Although not fully un-
derstood, a possible mechanism of action is through: (1) the production
of reactive species by CAP, which then diffuse into the cells or create
extra RONS inside the cells, e.g., due to lipid peroxidation; (2) an in-
crease in the level of intracellular RONS that oxidize proteins, lipids,
and DNA; (3) oxidation exceeding the anti-oxidant capacity of the cells
leads to irreversibly damaged biomolecules, which in turn induces a
physiological response through cell death. Therefore, to gain further
insight into these processes, it is necessary to study the interaction
between CAP and cells on a molecular level.
As proteins are the main facilitators of biological functions (and
account for about 50% of the gross dry weight of cells), one could
hypothesize that plasma-protein interactions will be key determinants
of the cell's fate after plasma treatment. Recent investigations have
shown that CAP can affect infectious prion protein [16], recombinant
green fluorescent protein [17], lysozyme [18], and globins, such as
hemoglobin and myoglobin [19] through modification of the higher-
order structure and/or heme degradation. Proteins of a particular in-
terest to investigate the plasma-protein interactions would be redox-
sensitive proteins, as they are centrally involved in regulating the redox
balance inside the cell, mainly through oxidative modification of redox-
sensitive cysteine residues [20]. One such protein is cytoglobin (CYGB).
CYGB is a recently discovered hexa-coordinated globin with many
proposed functions, including oxygen transport, NO-dioxygenase ac-
tivity [21,22], reactive oxygen species (ROS)-scavenger [23], and
tumor suppression [24]. Although some of these proposed functions are
still under debate, there is a general consensus that CYGB can protect
the cell from oxidative stress. This implies that CYGB is a redox-sensi-
tive protein, of which the sensitivity has been suggested to occur
through heme-coordination and/or cysteine residues (Cys38 and Cys83)
on its surface, which can form intra- or intermolecular disulfide bridges
[25–27]. Treating CYGB with plasma would allow for the verification
and further clarification of the proposed models on how plasma-in-
duced RONS affect biomolecules. Furthermore, it can shed new light on
recent findings [28–30] concerning how CYGB is involved in cell pro-
tection against oxidative stress.
In this study, recombinant CYGB was treated with a cold plasma jet
(kINPen IND) for different treatment times. Possible structural mod-
ifications were investigated by using electronic circular dichroism (CD),
UV–Vis spectroscopy, and resonance Raman spectroscopy. Additionally,
mass spectrometry (MS) experiments were performed on the native
form and under denaturing conditions. Finally, molecular dynamics
(MD) and docking simulations were performed to assess the effect of an
intramolecular disulfide bond on the structure and function of mono-
meric CYGB. These combined experiments and simulations allow us to
gain an insight into the effect of plasma treatment, and also oxidative
stress, on structural features of proteins, which should contribute to a
better understanding of the above-mentioned postulated functions of
CYGB.
2. Experimental
2.1. Expression and purification of recombinant CYGB
The expression of recombinant wild-type CYGB was performed as
previously described [31]. Briefly, human cDNA of CYGB was cloned in
the pET3a expression vector. Inclusion bodies were solubilized in 6M
guanidinium hydrochloride and insoluble material was eliminated.
Afterwards, CYGB was reconstructed by adding free hemin and dialyzed
overnight. The samples were then purified with an Akta purifier system
on a Hitrap DEAE-Sepharose column (both GE Healthcare, Life Sci-
ences). The concentrated material was loaded onto a Sephacryl S-200
High resolution column (GE Healthcare). The final purity of the pooled
CYGB was checked by absorbance spectra and SDS-PAGE.
2.2. CAP treatment of recombinant CYGB
A recombinant CYGB stock solution (19.3 mg/mL; 901 µM) was
diluted either in deionized water or 50mM tris-buffer (pH 8) to a final
concentration of 20 µM. Plasma treatment was performed on 500 µL
aliquots in a 24-well plate (on ice) for different time points (30 s, 1 min,
3min, 5min, 10min) using the kINPen IND plasma jet (neoplas GmbH).
The applied gas flow rate and gap distance were set at 3 L/min, and
10mm, respectively, for all treatments. Argon was used as feed gas.
After treatment, the evaporated volume of the aliquots was calculated
and replaced by either water or tris-buffer. The treated samples were
immediately put on ice before being handled for further analysis.
The pH of both used solvents was measured before and after treat-
ment with CAP at different lengths of time to assess the effect of CAP
treatment on the pH of the samples. The pH was measured with the
pHenomenal pH 1100H pH-meter (VWR).
2.3. Mass spectrometry
2.3.1. Native and denatured MS
Before native MS analysis, 50 µL of each sample was buffer ex-
changed using a Micro Bio-Spin P-6 Gel column (Bio-Rad) equilibrated
with 100mM aqueous ammonium acetate (pH 6.8), according to the
manufacturer's protocol. Afterwards, the samples were further diluted
to a concentration of 10 µM.
3 µL of sample solution were loaded into an in-house produced, gold
coated nano-electrospray ionization (ESI) glass capillaries and mounted
in the needle holder of the instrument. MS spectra were acquired on a
Synapt G2 HDMS instrument (Waters, Wilmslow, UK) using the fol-
lowing instrument parameters: 1.6 kV spray capillary voltage; 100 V
sampling cone; 3 V extractor cone; 6.3 mbar backing pressure; 15 V and
5 V collision energy in the trap (2.4×10−2 mbar) and transfer
(2.5× 10−2 mbar) cell, respectively; 45 V trap DC bias; 180mL/min
and 90mL/min He and IMS gas flow, respectively. The ions were se-
parated in the ion mobility (IM) cell, using nitrogen gas and a wave
velocity of 750m/s and a wave height of 40 V.
The samples were also measured under denaturing conditions by
diluting the sample 1:1 with acetonitrile containing 1% formic acid.
The MS parameters for measuring the denatured samples were: 1.4 kV
spray capillary voltage; 25 V sampling cone; 1 V extractor cone;
2.7 mbar backing pressure; and 5 V collision energy in trap
(2.00×10−2 mbar) and transfer (2.2× 10−2 mbar) cell. Settings for
IM separation were the same as under native conditions. Additional
native and denaturing measurements on the tris-diluted CYGB samples
were also performed in 10mM dithiothreitol (DTT).
2.3.2. In solution protein digestion and MS
To detect oxidative modifications at amino acid level, a tryptic di-
gest was performed on each treated sample following our own protocol.
Briefly, 40 µg of plasma-treated sample was used. 1% RapiGest SF
Surfactant (Waters) was added to a final concentration of 0.1% before
incubation for 5min at 100 °C. 200mM TCEP (tris (2-carboxyethyl)
phosphine) was added to reduce the sample. After 1 h incubation at
55 °C, 375mM 2-iodocetamide was added and further incubated for
30min in the dark to alkylate the sample. After alkylation, the sample
was precipitated with pre-chilled acetone and incubated overnight at
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− 20 °C. The acetone-precipitated pellet was resuspended in 100mM
triethylammonium bicarbonate to a final concentration of 1 µg/µL be-
fore MS grade trypsin protease (Thermo Scientific) was added to a final
protease-protein ratio of 1:40 (w/w). Tryptic digest was performed
overnight at 37 °C. The enzymatic reaction was stopped by freezing the
samples at − 20 °C. The digested samples were measured using liquid
chromatography – ion trap tandem mass spectrometry (LC-MS/MS).
The peptide mixture was separated by reversed phase C18 (RP-C18)
liquid chromatography on a nanoAcquity UPLC system (Waters) using a
Symmetry C18 trap column (5 µm particle size; 280 µm × 20mm)
connected to a BEH C18 analytical column (1.7 µm particle size;
100 µm × 100mm) (Waters). Before loading, each sample was dis-
solved in 10 µL mobile phase A (0.1% formic acid in 100% water) and
in total 1 µg of protein digest was loaded onto the column. A linear
gradient of mobile phase B (0.1% formic acid in 100% acetonitrile)
from 5% to 55% in 50min followed by a steep increase to 100% mobile
phase B in 3min was used at a flow rate of 400 nL/min. The nano-UPLC
system was coupled online with the mass spectrometer using a PicoTip
Emitter (New objective) and a nanospray ion source (Thermo
Scientific). The LTQ ion trap mass spectrometer (Thermo Scientific) was
set up in MS mode, where a full MS1 scan (300–2000m/z) was followed
by collision-induced dissociation (CID) and a subsequent MS2 scan
(100–2000m/z). All scans were acquired in the linear ion trap with an
automatic gain control (AGC) set at 3× 104 ions for MS1 and 1×104
ions for MS2 scans. The normalized collision energy was 31% in CID,
and a dynamic exclusion list of 30 s for data dependent acquisition was
used. Between every sample a blank run was performed to exclude any
possible carry-over effect.
Proteome Discoverer (2.1 SP1) software (Thermo Scientific) was
used to perform database searching against the UniProt reference
human database using both the Sequest and Mascot algorithms.
Following settings were applied: precursor mass tolerance of 500 ppm,
fragment mass tolerance of 0.50 Da. Trypsin was specified as digesting
enzyme and 2 missed cleavages were allowed. Cysteine carbamido-
methylation was defined as fixed modification and oxidations (on re-
sidues M/Y/D/F/H/W/N and P) were set as variable modifications. The
results were filtered using the following settings: only medium and high
confident peptides with a global FDR< 5% based on a target-decoy
approach [16] and first ranked peptides were included in the results.
2.4. UV–vis spectroscopy
UV–vis circular dichroism (CD) and absorption spectra were col-
lected using a Chirascan Plus qCD (LAAPD solid-state detector) spec-
trometer (Applied Photophysics Ltd.) operating with a bandwidth of
1 nm, a step size of 1 nm, a scanning speed of 0.5 s/nm, a sample
temperature of 20 °C and a cuvette with a path length of 0.5 mm or
2.0 mm. The spectral region sensitive to secondary structure
180–280 nm was measured using a 0.5 mm path length and the spectral
region 225–600 nm comprising the Soret band and Q-bands was mea-
sured with a path length of 2.0mm.
2.5. Resonance Raman spectroscopy
Resonance Raman (RR) spectra were acquired using a Dilor XY-800
spectrometer in low-dispersion mode using a liquid N2-cooled CCD
detector. The excitation source was a Spectra Physics (Mountain View)
BeamLok 2060 Kr+ laser operating at 413.1 nm. The spectra were re-
corded at room temperature and the protein solutions were magneti-
cally stirred at 500 rpm in order to avoid local heating and photo-
chemical decomposition. The slit width used during the experiments
was 200 µm. In general, 10–12 spectra were acquired with an integra-
tion time of 240 s each. Spikes due to cosmic rays were removed by
omitting the highest and lowest data points for each frequency and by
averaging the remaining values. Typical sample concentrations were in
the order of 20 μM.
2.6. Computer simulations (molecular dynamics and docking)
Molecular dynamics (MD) and docking simulations were performed
in order to elucidate the functionality of monomeric CYGB with and
without an intramolecular disulfide bridge, at the molecular level. The
simulations were carried out using the GROMACS [32] program
package (version 5.1), applying the GROMOS 45a3 force field [33]. The
coordinate file (with the initial configuration) of monomeric CYGB was
obtained from the Protein Data Bank (PDB ID: 1V5H) [34]. The struc-
ture of CYGB without an initial disulfide bond, i.e. CYGBSH…SH, was
placed in a dodecahedron box, with size chosen in such a way that there
initially was 1.0 nm buffer distance between the protein and the
boundary of the simulation box. This was done in order to avoid long
distance interactions (i.e. Coulomb and van der Waals interactions)
between CYGBSH…SH and its periodic images. The box was then filled
with water molecules surrounding the CYGBSH…SH molecule, employing
the SPC water model [35], and sodium counter ions were added to
neutralize the system. Periodic boundary conditions were applied in all
directions.
In order to study the effect of the abovementioned disulfide bond on
the conformation of CYGB, this disulfide linkage was manually created
using Avogadro software [36]. Subsequently, energy minimization was
applied to optimize the modified structure, using the steepest descent
algorithm. The measured length of the disulfide bond after the energy
minimization was 2.05 Å, which is exactly the same as the disulfide
bond length given in literature [37,38]. The abovementioned MD pro-
cedure was then repeated (i.e., the creation of the box and addition of
water molecules, as well as counter ions) to create the simulation
system with CYGB containing a disulfide bridge, i.e. CYGBS-S.
Thus, two model systems were used (i.e., CYGBSH…SH and CYGBS-S)
covered with water as a starting structure for the calculations. The
systems were minimized in three steps, by applying three optimization
algorithms, i.e., steepest descent, conjugate gradient and low-memory
Broyden-Fletcher-Goldfarb-Shanno (L-BFGS) [39]. Subsequently, a
500 ps equilibration run was performed employing the NVT ensemble
(i.e., a system with constant number of particles N, volume V and
temperature T). Next, a 150 ns production run was performed using
NPT dynamics (i.e., a system with constant number of particles N,
pressure P and temperature T). The NPT simulations were carried out
for 300 K and 1 bar pressure, employing the velocity-rescaling ther-
mostat with a coupling constant of 0.1 ps and the isotropic Parrinello-
Rahman barostat [40,41], with a compressibility and coupling constant
of 4.5× 10−5 bar−1 and 2 ps, respectively. A 1.4 nm cut-off distance
was applied for the van der Waals interactions. The long range elec-
trostatic interactions are described by the particle mesh Ewald (PME)
method [42], again using 1.4 nm cut-off for the real-space interactions
in combination with a 0.15 nm spaced-grid for the reciprocal-space
interactions.
In the docking simulations, binding hot spots of equilibrated
CYGBSH…SH and CYGBS-S were predicted using the FTMap family of the
web server [43]. FTMap samples the positions of 16 small probing or-
ganic molecules and identifies potential ligand binding regions of the
protein based on the lowest binding free energy. These individual
probing molecules may bind at various locations of the protein, and
thus their clusters specify binding hot spots (so-called binding pockets)
of the protein. The probing molecules used in the FTMap server are
ethane, ethanol, isopropanol, isobutanol, acetonitrile, methanamine,
N,N-dimethylformamide dimethyl ether, benzaldehyde, benzene, cy-
clohexane, phenol, acetamide, acetone, acetaldehyde and urea. They
vary in shape, size and polarity, and can be considered as drug-like
molecules [43]. The hot spot of the protein was identified by means of a
mapping algorithm that consisted of the following four steps: (1) each
probe molecule samples on a grid around the fixed protein. The energy
function considers van der Waals energy with attractive and repulsive
contributions and an electrostatic as well as solvation term character-
ized by the Poisson–Boltzmann continuum model. The algorithm choses
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the 2000 best positions of each probing molecule and proceeds to the
next stage. (2) These best positions of the probe molecules with the
protein complex are energy minimized using the CHARMM potential
[44] with an analytical continuum electrostatics model [45]. During the
energy minimization run, the protein atoms are fixed while the probing
molecules are free to move. (3) The minimized structures are clustered
within a 4 Å radius, considering the lowest energy structure. For each
probe molecule, six clusters are retained with the lowest energy, which
are ranked by their Boltzmann averaged energies. (4) The clusters of the
16 different probe molecules are then clustered into consensus clusters.
This clustering stage defines the center of mass for each cluster probe.
The highest ranked consensus cluster is selected, using the distance
between the centers of mass of the cluster centers as measure for the
distance and 4 Å as the clustering radius. VMD [46], and Pymol [47]
visualizing tools were used for preparation of the images.
3. Results
3.1. Spectroscopic changes upon plasma treatment of CYGB
As an initial study of the structural effects of plasma treatment on
CYGB, UV–vis absorption and CD spectra were recorded and are pre-
sented in Fig. 1. The UV–vis absorption spectrum of the untreated
sample contains a Soret (γ) band at 417 nm, and β and α bands in the
visible region of the spectrum at 535 and 565 nm, respectively, in-
dicating that the heme iron is in a ferric low-spin HisF8-Fe(III)-HisE7
hexa-coordination state [48]. The treatment of CYGB with plasma in-
duces significant spectroscopic changes. Most noteworthy is the time-
dependent disappearance of the Soret band, but also the steady de-
crease of the intensity of the β and α bands with longer treatment times.
When comparing the spectra, acquired in the two solvents that were
employed, both similarities and differences can be observed. For both, a
time-dependent decrease in intensity of the Soret band can be observed.
However, the Soret band of the samples diluted in tris-buffer is still
clearly visible after 5min exposure to plasma. Even after 10min, there
is still positive intensity discernible at 417 nm in tris-buffer, while this
is not the case in water. Even more so, in water, a new peak appears at
387 nm after 5min of treatment, indicating that free heme is present in
the solution [49]. In tris-buffer, the same peak (383 nm) only starts to
appear after 10min treatment, again indicating the presence of free
heme.
The CD spectra of CYGB before and after treatment are shown in
Fig. 1C and D. All spectra display the typical double minima at 208 and
222 nm, characteristic for protein structures that are predominantly α-
helical [50]. Plasma treatment, besides altering the intensity of the
double minima, does not seem to influence the spectra significantly,
suggesting that the secondary structure remains largely unaltered by
the plasma treatment. As the ϴ222/ϴ208 ratio is sensitive to structural
changes, the ratio was plotted over treatment time (Fig. 1E) [50]. The
plot shows that, with both solvents, the ratio drops depending on the
treatment time. The change in the ratio, although very minor, indicates
a slight unfolding of the protein.
pH measurements indicated that the pH of the samples dissolved in
water significantly drops after plasma treatment, whereas with tris-
buffer, no change in pH could be observed (Fig. S3). As the change in
pH of water could have a profound effect on CYGB, and thus on the
Fig. 1. Spectroscopic changes of CYGB after plasma treatment. UV–vis spectra of untreated and plasma-treated CYGB in (A.) water, and (B.) tris-buffer, in the
350–600 nm region with the Soret band (417 nm) and β (535 nm) and α (565 nm) bands clearly visible. (C) and (D): CD spectra of untreated and plasma-treated
CYGB samples in the 190–250 nm region, depicting the double minima at 208 nm and 222 nm typical for alpha helical structures. (E): Change of the 208/222 nm
ratio in function of the treatment time with both used solvents.
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results obtained with this solvent, we decided to focus further only on
the results obtained with tris-buffer.
3.2. Mass spectrometry experiments
Following the UV–vis and CD measurements, mass spectrometry
(under native and denaturing conditions) was used to assess changes in
the tertiary structure of CYGB samples as well as chemical modifica-
tions after treatment with plasma.
3.2.1. Native MS
Fig. 2 shows the native mass spectra of untreated and treated CYGB.
The spectrum of the untreated sample (“control”) clearly exhibits a
charge state distribution for monomeric and dimeric species, with the
monomeric species accounting for the majority of the signal (see also
Fig. S1). As can be seen, plasma treatment not only leads to peak
broadening and a shift to higher m/z values, but also to a small increase
of dimeric species. The peak shift and broadening is highlighted (in
blue) for the monomeric + 9 species in the m/z region of 2400–2600
(Fig. 2, inset). Here, it can be seen that plasma treatment of only 30 s
already causes a mass shift to higher m/z values and peak broadening,
which indicates an unresolved distribution of oxidized species. Not
much change is observed up to 3min treatment of CYGB. However, a
major peak shift is visible after 5 and 10min of treatment, which is
probably caused by binding of an additional ligand to the heme (see
further, Fig. 3). In addition, a small fraction of apo-CYGB is also pre-
sent, in agreement with UV–vis data that showed heme loss after 10min
as well.
3.2.2. Denatured MS
Plasma-treated samples were also measured under denaturing con-
ditions, in order to determine if the observed dimers were noncovalent
complexes, or covalently linked, e.g. via disulfide bridges (Fig. 3). As
can be seen in Fig. 3(B) (bottom panel, “control”) and Fig. S2, unfolding
leads to a much broader charge state distribution for the monomer that
no longer contains the heme group. The spectra also show minor peaks
in between the monomers (Fig. 3B), highlighting the presence of di-
meric species that still remain after denaturation. This indicates that the
dimerization occurs via covalent bonds. In Fig. 3(A), the m/z region
between 600 and 700 is shown with the peak corresponding to the free
heme group (616m/z). A plasma treatment time of up to 3min does not
show much effect; however after 5min a new peak appears at 661m/z,
indicating the binding of a molecule to the heme group (while also
replacing a hydrogen atom) which we interpret as •NO2 (+45 Da).
We note that dimers are already present in the native spectra
(Fig. 2) without plasma treatment, but almost entirely absent in the
denatured spectrum (Fig. 3A). In order to investigate whether pre-ex-
isting noncovalent CYGB dimers are converted to covalent, disulfide-
bound dimers under the influence of plasma oxidation, measurements
in tris-buffer, under native conditions, were repeated after adding
10mM of the reducing DTT to the samples. Fig. 4 shows the full spectra
and zoomed in section of the monomeric +9 peak (inset, highlighted in
blue). As can be observed, addition of DTT leads to a loss of the dimeric
species, indicating that dimerization is stabilized by disulfide bonds.
Furthermore, the addition of DTT also reduces the plasma-induced
oxidations. This is clearly visible when comparing the monomeric +9
peaks in Fig. 4 with the ones depicted in Fig. 2, under otherwise
identical conditions. The peak shifts after 5 and 10min of plasma
treatment again indicate binding of an additional ligand to the heme
group.
3.3. Amino acid modification sites of CYGB
Next, we aimed to map plasma-induced oxidative modification sites
using LC-orbitrap MS/MS of trypsin-digested samples. Table 1 gives an
overview of different types of amino acids that were found to be
modified after plasma treatment of a specific duration. CAP was able to
oxidize all different amino acids that were selected for the analysis
(Table 1), with some seeming to be more readily oxidized than others.
Of the investigated amino acids, methionine, tryptophan, and tyrosine
were the three found to be preferably oxidized, as reported previously
[51]. Surprisingly, no clear treatment-time-dependent increase in the
number of oxidized amino acids could be observed, indicating that
oxidation may occur rapidly. In the suppl. Table S2, the complete amino
acid sequence of CYGB is given together with the specific location of
each identified modification, for each exposure time. Table S2 shows
that some of the amino acids, at certain locations, were never oxidized.
For example, two of the six methionine and two of the five tyrosine
(Met66, Met72, Tyr59, and Tyr123) were not found to be oxidized, under
any condition.
Table 2 gives the total number of identified peptide fragments (so-
called ‘Peptide Spectrum Matches’, PSM), together with the number of
oxidized PSMs. Here, a clear treatment-time-dependent increase in
oxidized peptides can be observed, illustrating the increasing oxidation
potential with increasing treatment time. It is also noticeable (Tables 1,
2 & S2) that in the control samples some amino acids (M,Y and F) are
also oxidized. This oxidation is likely due to the exposure of the sample
to the surrounding atmosphere, or may occur during electrospray.
3.4. MD and docking simulations
CYGB possesses two cysteine residues (Cys38 and Cys83), which are
known to be able to form disulfide bridges, either inter- or in-
tramolecularly [25,26]. As CYGB is proposed to be a monomer in vivo
[52], and the formation of an intramolecular disulfide bridge can
Fig. 2. Native MS. Native MS spectra of 10 µM holo CYGB in 100mM ammo-
nium acetate after different duration of plasma treatment (20 µM CYGB in
50mM tris-buffer). Monomeric (+10, +9, +8) and dimeric (+14, +13, +12)
species are identified. The monomeric +9 species are highlighted in blue. Inset:
zoomed in section of the +9 monomers, highlighting mass shifts and peak
broadening caused by plasma-induced oxidations. The theoretical mass of holo
CYGB is 22,021.11 Da.
J. De Backer et al. Redox Biology 19 (2018) 1–10
5
influence the activity of CYGB, we chose to investigate the effect of the
formation of an intramolecular disulfide bridge in between the cysteine
amino acids of monomeric CYGB (i.e., CYGBS-S) with MD simulations.
We have shown experimentally that an intermolecular disulfide bridge
is present in the dimeric fraction. However, we can also speculate that
the monomeric fraction may contain an intramolecular disulfide bridge.
Fig. 5 illustrates the last snapshots of the equilibrated CYGBSH…SH (i.e.
CYGB monomer without an initial disulfide bond) and CYGBS-S mole-
cules (i.e. CYGB monomer with an intramolecular disulfide bond) de-
picted in yellow and green, respectively. The F-helix of CYGB is located
at the proximal side of the heme group, while the E-helix is positioned
at the distal side. The disulfide linkage in CYGBS-S clearly influences its
conformation and hence, the positions of the E- and F-helices are shifted
Fig. 3. Denaturing MS of CYGB. ESI spectra of 10 µM CYGB (diluted 1:1 in acetonitrile containing 1% formic acid) after different duration of plasma treatment
(20 µM CYGB in 50mM tris-buffer). (A.): Zoomed in m/z region from 600 to 700. The peak at 616.3440m/z represents the free heme group. 5–10min of treatment
induces binding of a molecule, i.e. •NO2 to the heme group (661.3398m/z). (B.): Full spectrum ranging from 800 to 4000m/z showing the apo-form of the protein.
The appearance of smaller peaks (asterisks) in between the monomers highlights the presence of covalent dimers in the sample. The theoretical mass of CYGB in the
apo-form (without heme) is 21 404.62 Da compared to the experimental mass of 21 407.29 ± 4.16 Da in the control.
Fig. 4. Native MS after reduction with DTT. Native MS spectra of 10 μM
CYGB in 100mM ammonium acetate after adding 10mM DTT. Monomeric +9
is highlighted. Inset: the zoomed in section of the monomeric +9 peak.
Addition of DTT leads to a loss of the dimers via reduction of disulfide bridges.
DTT also seems to reduce the number of oxidations (narrowing of the peaks).
See also Fig. 2 for comparison.
Table 1
Oxidative modifications of CYGB. A list of the number of different amino
acids in CYGB (# AA in sequence) and the number of oxidized amino acids of
each type before (control) and after different treatment times. Eight amino
acids (M, Y, D, F, H, W, N, and P) were chosen for analysis. Samples were
measured with Ion trap LC-MS/MS and spectra were analyzed with Mascot and
Sequest algorithms.
Tris-buffer
Amino Acid # AA in
sequence
Control 30 s 1min 3min 5min 10min
Methionine (M) 6 2 3 4 4 3 4
Tyrosine (Y) 5 2 3 3 2 3 2
Tryptophan (W) 3 1 2 2 2 2
Phenylalanine (F) 8 1 1 1 1 1 1
Aspartic acid (D) 5 1 2 2 1
Asparagine (N) 5 3 3 1 2
Proline (P) 13 1 3
Histidine (H) 6 1 1 1 1
TOTAL 51 5 12 16 13 13 14
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relative to CYGBSH…SH (cf. the yellow and green dashed lines). In order
to calculate the distances between the helices, residues Ala82 and Ala88
in the F-helix and Ala107 and Ala112 in the E-helix were chosen. These
amino acids are positioned at the end of the black dashed lines but they
are not shown in the figure for the sake of clarity. The calculated dis-
tances between these amino acids located in the E- and F-helices are
also given in Table S1, indicating the minor change in the modified
CYGBS-S. It is also obvious from Fig. 5 that there is a negligible shift of
the heme group in the modified CYGBS-S molecule compared to native
CYGBSH…SH. Hence, the formation of the disulfide bridge between the
cysteine residues does not alter the local orientation of the heme group
and imidazole planes of the histidines (i.e., His81, His113) bound to the
heme: the imidazole planes do not rotate versus each other. This was
also reported in literature by experimental investigations [53].
Comparing the consecutive MD frames of both monomeric
CYGBSH…SH and CYGBS-S, indicates that the His117 residue located
nearby the heme group (see Fig. 6) substantially changes its orientation
in CYGBS-S. Indeed, the calculated distance between the heme iron and
one of the nitrogen atoms of His117 (located in the imidazole ring) al-
most doubled in CYGBS-S (see Table. S1), which is due to the con-
formational change caused by the intramolecular disulfide bond. Be-
sides the change in orientation of His117, it is noticeable that the
propionate group of the heme closest to His117 flips its position upon
disulfide bond formation (facing downward in CYGBS-S; see Fig. 6(b)
and (d)). To get more insight into the structural changes caused by the
intramolecular disulfide bond, the binding hot spots of both
CYGBSH…SH and CYGBS-S were investigated as described in Section 2.
10 CYGB structures with 1 ns time interval were extracted using the
last 10 ns trajectory of the equilibrated (so-called production) run.
These structures were employed to examine the structural dependencies
of the binding hot spots of CYGB. Here, only one of the results out of ten
are presented, as the other nine results were very similar. Three dif-
ferent pockets (with lowest binding energies) were obtained in both
CYGBSH…SH and CYGBS-S, which are depicted as meshed regions in
Fig. 6. The other two meshed regions are not shown as we are focusing
on the catalytic site of CYGB (i.e., the heme pocket). As mentioned
above, the formation of a disulfide bond between the cysteine residues
leads to a change of the CYGB conformation, which results in a dou-
bling of the distance between the highly localized His117 residue and
the heme group in CYGBS-S (see Table S1 and cf. Fig. 6(a) and (c) or
Fig. 6(b) and (d)). Accordingly, this results in the heme group to be-
come more accessible to the probing molecules (see overlap between
heme group and meshed regions in Fig. 6(c) and (d)). In addition, the
flipping of the position of the heme propionate upon disulfide forma-
tion further contributes to the accessibility of the heme pocket
(Fig. 6(b) and (d)). Our binding hot spot analysis indeed shows that in
the case of CYGBS-S the binding pocket is located around the heme
group, whereas in CYGBSH…SH it is found with limited access to the
heme group, i.e., around the helices (cf. Fig. 6(a) and (c), or Fig. 6(b)
and (d)). This again confirms that in CYGBSH…SH the access to the heme
group is more limited than in CYGBS-S.
4. Discussion
In this study, it was shown that the treatment of recombinant CYGB
with CAP resulted in chemical modifications of the protein. The spectral
characteristics described for the untreated recombinant CYGB are
identical to the ones described previously, showing that the protein is in
the hexacoordinated ferric form [48]. Upon plasma treatment, spectral
changes occur, which appear to be dependent on the duration of the
treatment. These changes were more prominent when water was used
as a solvent than in tris-buffer. This suggests that in water, the effect of
plasma, which is mainly through reactive species production, is greater
than in tris-buffer. However, there is one main difference between the
two solvents that were employed: deionized water has no buffering
capacity, whereas tris-buffer does. As plasma treatment induces many
different reactive species (i.e. •OH, H2O2, •NO, O2−, ONOOH, •NO2,
NO2-, NO3-) [54], these species can contribute to the acidification of
liquids. Indeed, pH measurements highlighted that plasma treatment
induces a significant drop in the pH of deionized water, whereas no
such effect could be observed with tris-buffer (Fig. S3). Thus, with
water, there is a secondary effect of plasma treatment, through the
acidification of the sample. Low pH can, depending on the protein, lead
to protein denaturation and aggregation. In Fig. 1(A), after 5min
treatment, the Soret peak at 415 nm has almost completely dis-
appeared, and a new peak has emerged at 387 nm, indicating free heme
in the solution [49]. Additionally, the ultracentrifugation of the 5min
treated sample showed a clear brown precipitate, indicating the ag-
gregation and denaturation of the sample upon plasma treatment. In
tris-buffer, on the other hand, no clear precipitate after ultra-
centrifugation of the 5min treated sample could be observed, yet still,
clear spectral changes were observed. Altogether, this confirms that in
water, plasma treatment acidifies the solution, leading to structural
changes in the protein, and the eventual (partial) denaturation of the
protein sample. This has some implications for the further interpreta-
tion of the results from this study. As the main aim of this study was to
investigate the effects of plasma-generated RONS on CYGB, the results
obtained from treating CYGB with plasma in tris-buffer are of higher
relevance and will be discussed further in more detail (see Suppl. Figs.
S6 & S7 for MS spectra in water).
From the absorption spectra of the samples treated in tris-buffer, it
can be concluded that plasma induces a decrease in intensity of the
Soret band at 417 nm. This could indicate two things: the first option
would be that the protein is continuously degrading more with longer
treatment times, with the eventual, almost complete denaturation of the
Table 2
Oxidative modifications of CYGB. A list of the number of oxidized peptide
fragments before and after plasma treatment. The number of Peptide Spectrum
Matches (PSM) is the total number of identified peptide spectra matched for the
protein. Samples were measured with Ion trap LC-MS/MS and spectra were
analyzed with Mascot and Sequest algorithms.
Sample # PSM in total #Oxidation PSM % Oxidation
Tris-buffer Control 90 15 17%
30 s 121 23 19%
1min 223 44 20%
3min 117 34 29%
5min 109 38 35%
10min 138 54 39%
Fig. 5. Aligned structures of CYGBSH…SH (yellow) and CYGBS-S (green). The
distances between Ala88-Ala107 and Ala82-Ala112 are depicted by black dashed
lines. The yellow and green dashed lines are plotted to indicate shifted positions
of the E-and F-helices. The heme group and cysteine residues of both
CYGBSH…SH and CYGBS-S are presented in licorice view in blue and pink, re-
spectively. The disulfide (S-S) bridge is shown within the red dashed circle.
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protein at 10min treatment time. Although the appearance of a peak at
383 nm (after 10min treatment) indicates the leaking of the heme out
of the protein (and thus denaturing of the protein), CD and MS data
(Figs. 1E and 2) however shows that the largest fraction of the protein is
still folded and contains the heme group. The slight unfolding we see in
the CD-spectra may be explained by the MD data where it is shown that
the formation of an intramolecular disulfide bridge in CYGBS-S induces
a minor shift of the E- and F-helices, relative to CYGBSH…SH (see Table
S1 & Fig. 5). Furthermore, measurement of the drift time of the
monomeric (+9 peak) species showed that there was no significant
alteration of the collision cross section (CCS) of the treated protein (Fig.
S4), indicating that the three-dimensional shape, i.e. the tertiary
structure, is not significantly affected upon plasma treatment, and thus
excluding this option.
The second option would be that plasma treatment induces specific
chemical modifications in the protein that lead to the observed spectral
changes. The Soret band is emblematic for heme-containing proteins
such as globins and various cytochromes, and arises primarily due to π-
π * transitions in the heme group [55]. Binding of molecules to the
heme structure or close environment could affect the (electronic)
structure and lead to a decrease and/or shift of the Soret peak. From the
MS data, it is clear that there is indeed covalent modification of CYGB
upon plasma treatment. In Fig. 2, it can be seen that there is a peak shift
and broadening, indicating that plasma treatment induces numerous
oxidations, either at specific amino acids, or at the heme group.
Moreover, the MS spectra of the denatured sample (Fig. 3) clearly show
that, with 5 or 10min treatment, there is binding of a molecule, most
likely •NO2, to the protein bound heme group. Binding of •NO2 has al-
ready been shown to occur in vitro in other globins, i.e. myoglobin
[56], hemoglobin [57], and more recently leghemoglobin [58], by ex-
posing the proteins to excess NaNO2. In these studies, it was shown that
heme nitration originated from the substitution of a hydrogen atom by
•NO2 from one of the vinyl groups. The subsequent formation of a ni-
trovinyl group results in a modified visible spectrum (a Soret band with
lower intensity) and a heme group with m/z 661, similar to the results
that were obtained in this study. Addition of a 1000-fold excess of
NaNO2 to CYGB (data not shown) led to the same modified spectra
observed after plasma treatment of 5 and 10min, confirming the ni-
tration of the heme. Furthermore, resonance Raman (RR) experiments
further confirmed the binding of •NO2 to the heme (Fig. S5). The high-
frequency region of the RR spectra revealed the appearance of a strong
band at ~ 1325 cm−1, which is specific for a nitroaromatic group
[59–61], again indicating the binding of •NO2 to the vinyl groups of the
heme. Plasma treatment of liquids does indeed yield the formation of
•NO2 [62–64]. Thus, upon plasma treatment for 5min and longer, •NO2,
and most probably other related nitrogen species, are sufficiently pro-
duced in order to induce the binding of •NO2 to the heme. Furthermore,
the fact that •NO2 can bind to the CYGB heme could implicate that it
also performs a similar biological role, i.e. the involvement of CYGB in
NO homeostasis. Previous reports already proposed a role for CYGB in
NO regulation through its NO dioxygenase activity [26]. However,
under conditions of oxygen deprivation, CYGB could act as a source of
NO by switching to a nitrite reductase function. The switching between
these two functions is regulated through the oxidation of the two sur-
face-exposed cysteine residues [65].
Besides nitration of the heme, plasma induces the oxidation of
specific amino acid residues of CYGB. Here, the three most oxidized
amino acids were methionine, tryptophan, and tyrosine. In Takai et al.
[66] reported that plasma was able to chemically modify amino acids
through the oxidation of their side chains, with sulfur-containing (i.e.
Met and Cys) and aromatic amino acids (i.e. Trp, Tyr, and Phe) pre-
ferentially modified. Furthermore, they found that the relative re-
activity towards plasma treatment was Met>Cys>Trp>Phe>Tyr.
This is not entirely in agreement with our findings (Table 1). However,
in this study, a complete protein was treated with plasma, whereas in
the study of Takai et al., a mixture of amino acids was treated with
plasma. Therefore, it is highly likely that in CYGB, due to its 3D-
structure, some amino acids, e.g. Phe, are less solvent accessible com-
pared to when individual amino acids are studied, leading to different
results. This is further highlighted in Table S2, where it can be seen that
certain locations of preferably oxidized amino acids, such as Met and
Trp were never oxidized, indicating that the access of certain amino
acids is hindered due to the tertiary structure of CYGB. This observed
reactivity is in agreement with an increasing body of evidence from
other experimental approaches which utilize ROS to cause oxidation of
the solvent-accessible surface area of proteins, such as hydroxyl radical
footprinting by synchrotron radiation [51] as well as fast photo-
chemical oxidation of proteins [67] and other oxidative labelling
techniques [68].
As for cysteine, during the digestion of the protein sample prior to
measuring with LC-MS/MS, the cysteines are reduced by TCEP and
carbamidomethylated. This modification is introduced on purpose to
prevent disulfide bridges from forming again, and was therefore not
selected for the analysis of oxidative modifications [69]. Yet, from the
Fig. 6. Binding hot spots. Binding hot spot of CYGBSH…SH
(a-b) and (c-d) CYGBS-S presented as red meshed regions.
The helices in the structures are represented in pale colors,
for the sake of clarity. The heme group and the histidine
residues (81, 113, 117) are shown in green and light
purple colors and licorice views, respectively. It is clear
that in CYGBSH…SH the access to the heme group is more
limited than in CYGBS-S.
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MS data (Figs. 2 and 4) it is clear that cysteines do become oxidized
(i.e., formation of disulfide bridge). CYGB possesses two cysteine re-
sidues (Cys38 and Cys83), which are known to be able to form disulfide
bridges, either inter- or intramolecularly [25,26]. Such a formation of
CYGB dimers upon plasma treatment can indeed be observed in native
mass spectra (Fig. 2), and even more clearly under denaturing condi-
tions in Fig. 3. Moreover, the addition of the reducing agent DTT to
both the untreated and treated samples led to the disappearance of the
dimeric peaks in the spectrum (Fig. 4). However, there is still a sig-
nificant portion of CYGB that stays in the monomeric form (Fig. 2). It is
highly likely that the monomers that are still present after treatment
have formed intramolecular disulfide bridges. Although the dimeric
form of CYGB has been suggested to be less active than the monomeric
form (see paragraph below), this observed dimerization after treatment
could be an artefact of the experimental setup. In vivo, the concentra-
tion of CYGB lies somewhere between 0.1 and 5 µM, at which CYGB is
proposed to be a monomer [70]. Higher concentrations, like the one
that was used here, could bring CYGB molecules closer together and
subsequently stimulate the formation of dimers. Nonetheless, from the
abovementioned, we can conclude that plasma treatment leads to the
formation of intermolecular disulfide bridges, thereby stabilizing the
CYGB dimers, but presumably also intramolecular disulfide bridges in
the remaining monomers. This would confirm the two cysteine residues
as redox-active cysteines.
The state of the two surface-exposed cysteine residues, either free,
intra- or intermolecularly linked, has been proposed to be critical in
determining the biochemical and redox properties of CYGB [71]. A
recent study demonstrated a clear difference in the ability of CYGB to
bind lipids between the monomeric and dimeric form of the protein,
with the monomer, containing an intramolecular disulfide bridge, more
easily able to bind lipids [25]. This difference is suggested to occur
because the presence of an intramolecular disulfide bond leads to the
formation of a more open heme pocket structure, thereby facilitating
access for external ligands, such as lipids, whereas an intermolecular
disulfide bond does not alter the environment of the heme pocket [25].
This is perfectly in line with the MD and docking simulations performed
in this study on monomeric CYGB. Here, it is seen that in CYGBSH…SH,
the access to the heme group is more limited than in CYGBS-S. We
further found that the His117 residue plays a vital role in either limiting
or increasing the access to the heme group, thereby acting like a gate
function for CYGBSH…SH and CYGBS-S. Thus, our investigations confirm,
and further show, that the formation of an intramolecular disulfide
bond affects the CYGB structure, thereby opening the access to the
heme group, through gate functioning of His117, which in turn could
lead to a higher binding affinity. In addition the redox state of the Cys38
and Cys83 residues appears to act as a ‘molecular switch’, activating the
protein only under the correct conditions, i.e. oxidative stress. This
would support CYGB's proposed cytoprotective role in oxidative stress
conditions, which is probably linked to the lipid peroxidase activity of
the protein [25,49].
5. Conclusion
In conclusion, the treatment of CYGB with CAP leads to chemical
modifications of the protein, yet the overall structure of the protein
remains largely intact.
Short treatment times were already sufficient to induce the oxida-
tive modification of mainly sulfur-containing and aromatic amino acids.
Longer treatment times also lead to the nitration of the heme, through
the binding of •NO2 to the vinyl groups, which proposes a role for CYGB
in NO homeostasis. Upon plasma treatment the two cysteine residues of
CYGB were oxidized, which stabilizes the dimeric CYGB, through in-
termolecular disulfide bridges, but most likely also monomeric CYGB
containing an intramolecular disulfide bond. The simulations per-
formed in this study also confirm the importance of the oxidation of
Cys38 and Cys83 residues in regulating the ligand-binding properties,
and thus also the activity, of CYGB. Furthermore, His177 was found to
play a vital role in regulating the access to the heme group.
As mentioned in the introduction, the aim of this study was to
elucidate the effects of plasma-generated (and in general) RONS on the
structure and, to some extent, the function(s) of CYGB. Although some
protein denaturing occurred, our results nonetheless confirm that
(plasma-generated) RONS can indeed induce chemical modifications at
specific sites, which lead to different conformations of CYGB. These
different conformations are mediated by the oxidation status of two
redox-active cysteines. As globins (more particularly hexacoordinated
globins) are increasingly hypothesized to play a role in redox biology,
findings here seem to further support the idea of CYGB functioning as a
redox-active protein.
This study is of great interest because it provides further support
and new insights that CYGB, on a molecular basis, has the potential to
play a role in the cellular response against oxidative stress. However,
further research on a cellular level is needed to validate these findings
and to unravel the cellular pathways in which CYGB is involved. Such
research should focus on elucidating the effects of (plasma-generated)
RONS on cells and the role of CYGB in the response to these RONS.
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